Skip to Main Content

Author Details

Heidi V N K??sters-Vandevelde
Canisius Wilhelmina Hospital
2006
46
18
PMIDPaper TitleJournal TitlePublished Year
37975702Subnodal Correspondence of PSMA Expression and USPIO-MRI in Metastatic Pelvic Lymph Nodes in Prostate Cancer.Invest Radiol2024
37230883Head-to-Head Comparison of <sup>18</sup>F-PSMA-1007 Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging with Whole-mount Histopathology as Reference in Localisation and Staging of Primary Prostate Cancer.Eur Urol Oncol2023
35771253Intratumoral T cell depletion following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is associated with poor clinical outcome.Cancer Immunol Immunother2023
37455399Immunohistochemical and histopathological validation of <sup>18</sup> F-PSMA-1007 PET/CT for intraprostatic cancerous lesions.Prostate2023
37081760Pure and mixed clear cell carcinoma of the endometrium: A molecular and immunohistochemical analysis study.Cancer Med2023
37174070Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer.Cancers (Basel)2023
32972895Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy.Eur Urol Oncol2022
35543733Lymph node staging with fluorine-18 prostate specific membrane antigen 1007-positron emission tomography/computed tomography in newly diagnosed intermediate- to high-risk prostate cancer using histopathological evaluation of extended pelvic node dissection as reference.Eur J Nucl Med Mol Imaging2022
35439175How Image-Guided Pathology Can Improve the Detection of Lymph Node Metastases in Prostate Cancer.Clin Nucl Med2022
36525269Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.JAMA Netw Open2022
36167598How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come.Eur Urol2022
36096975The amount of preoperative endometrial tissue surface in relation to final endometrial cancer classification.Gynecol Oncol2022
36384753Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer.Int J Gynecol Cancer2022
35204526Computer-Aided Assessment of Melanocytic Lesions by Means of a Mitosis Algorithm.Diagnostics (Basel)2022
34471231Preoperative PSMA-PET/CT as a predictor of biochemical persistence and early recurrence following radical prostatectomy with lymph node dissection.Prostate Cancer Prostatic Dis2022
33858677Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.Gynecol Oncol2021
31523803Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort study.Int J Cancer2020
32088104External validation of the Martini nomogram for prediction of side-specific extraprostatic extension of prostate cancer in patients undergoing robot-assisted radical prostatectomy.Urol Oncol2020
32022266Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.Int J Cancer2020
32413043Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study.PLoS Med2020
32409160Fallopian tube abnormalities in uterine serous carcinoma.Gynecol Oncol2020
30428390Quantification of Leydig cells and stromal hyperplasia in the postmenopausal ovary of women with endometrial carcinoma.Hum Pathol2019
31186375Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.Oncologist2019
31283116[A rare nodule on the finger].Ned Tijdschr Geneeskd2019
31011231Poor outcome in hypoxic endometrial carcinoma is related to vascular density.Br J Cancer2019
30972225Validation of Whole-slide Digitally Imaged Melanocytic Lesions: Does Z-Stack Scanning Improve Diagnostic Accuracy?J Pathol Inform2019
31103324Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer.Gynecol Oncol2019
30716025From Detection of Individual Metastases to Classification of Lymph Node Status at the Patient Level: The CAMELYON17 Challenge.IEEE Trans Med Imaging2019
29476293Whole-exome sequencing of a meningeal melanocytic tumour reveals activating CYSLTR2 and EIF1AX hotspot mutations and similarities to uveal melanoma.Brain Tumor Pathol2018
27974237Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis.Exp Mol Pathol2017
27988846Copy number variations as potential diagnostic and prognostic markers for CNS melanocytic neoplasms in neurocutaneous melanosis.Acta Neuropathol2017
26769193SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas.Acta Neuropathol Commun2016
25315378Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms.Pathol Oncol Res2015
25756553Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas.Melanoma Res2015
25534128Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects.Brain Pathol2015
23241791Does loupe magnification reduce the gap between the macroscopic and microscopic border of a Basal cell carcinoma?: a prospective clinical study.Ann Plast Surg2014
25593912Update on Molecular Pathology of Cutaneous Melanocytic Lesions: What is New in Diagnosis and Molecular Testing for Treatment?Front Med (Lausanne)2014
24802725NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract--a study of 24 cases from the Netherlands.Gynecol Oncol2014
24713450Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.Acta Neuropathol Commun2014
23303902Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes.Cancer Discov2013
19739123CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin.Int J Cancer2010
20865267Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis.Acta Neuropathol2010
19936769Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system.Acta Neuropathol2010
18681909Expression of p14ARF, p16INK4a and p53 in relation to HPV in (pre-)malignant squamous skin tumours.J Cell Mol Med2009
18205010Occurrence of ocular melanoma thirteen years after skin melanoma: two separate primaries or metastatic disease? A case solved with NRAS and CDKN2A (INK4A-ARF) mutational analysis.Virchows Arch2008
16772234Alternaria infectoria phaeohyphomycosis in a renal transplant patient.Med Mycol2006
  • 1 - 46 of 46

Recommended Authors

Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2015
Number of shared co-authors 0
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 2012
Number of shared co-authors 0
University Hospital Zurich
Career Start Year 2009
Number of shared co-authors 1
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 0
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2008
Number of shared co-authors 0
University of Cincinnati College of Medicine
Career Start Year 2007
Number of shared co-authors 0
Mayo Clinic Foundation
Career Start Year 2007
Number of shared co-authors 0
University Hospital of Zurich
Career Start Year 2007
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 3
Charite University Medicine Berlin
Career Start Year 2005
Number of shared co-authors 1
Westmead Hospital
Career Start Year 2004
Number of shared co-authors 1
Tufts Medical Center
Career Start Year 2004
Number of shared co-authors 0
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 2
Diagnostic and Research Institute of Pathology, Medical University of Graz
Career Start Year 2003
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 2003
Number of shared co-authors 0
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 0
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 0
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 1
Washington University School of Medicine and Siteman Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Institut Curie
Career Start Year 1999
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 0
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year 1995
Number of shared co-authors 0
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1993
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 1
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 1
Saint John's Cancer Institute at Saint John's Health Center
Career Start Year 1982
Number of shared co-authors 0
QIMR Berghofer Medical Research Institute
Career Start Year 1982
Number of shared co-authors 1
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Netherlands Cancer Institute
Co-authored papers 6
Radboud University Medical Center
Co-authored papers 4
1Rijnstate Hospital
Co-authored papers 4
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center
Co-authored papers 1
Co-authored papers 1
Radboud University Medical Center
Co-authored papers 1
Eindhoven University of Technology
Co-authored papers 1
St. Antonius Hospital
Co-authored papers 1
Massachusetts General Hospital, Harvard University
Co-authored papers 1
Co-authored papers 1
Radboud University Medical Center
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
Eindhoven University of Technology
Co-authored papers 1
Co-authored papers 1
Johns Hopkins University School of Medicine
Co-authored papers 1
Radboud University, Nijmegen Medical Centre
Co-authored papers 1
Radboud university medical center
Co-authored papers 1
Alrijne Hospital Leiderdorp
Co-authored papers 1
Co-authored papers 1
Radboud University Medical Center
Co-authored papers 1
Co-authored papers 1
Radboud University Medical Center
Co-authored papers 1
Radboud Institute for Health Sciences, Radboud University Medical Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Huazhong University of Science and Technology
Co-authored papers 1
The Chinese University of Hong Kong
Co-authored papers 1
Graduate School of Medicine, The University of Tokyo
Co-authored papers 1
Princess Maxima Center for Pediatric Oncology
Co-authored papers 1
Co-authored papers 1